Loading insider details...
Latest Form 4 (Jun 30, 2026): Grant/Award of 1,284 MNPR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 30, 2026 | Monopar Therapeutics (MNPR) | Grant/Award | 1,284 | n/a |
| Jun 11, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Disposition to Issuer | 59,291 | n/a |
| May 27, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Exercise/Conversion | 5,000 | n/a |
| May 26, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Exercise/Conversion | 6,250 | n/a |
| Apr 20, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Exercise/Conversion | 6,250 | n/a |
| Feb 25, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Exercise/Conversion | 6,250 | n/a |
| Jan 21, 2026 | KalVista Pharmaceuticals, Inc. (KALV) | Grant/Award | 100,000 | n/a |
| Dec 4, 2025 | KalVista Pharmaceuticals, Inc. (KALV) | Exercise/Conversion | 6,250 | n/a |
| Aug 27, 2025 | KalVista Pharmaceuticals, Inc. (KALV) | Exercise/Conversion | 5,000 | n/a |
| Aug 26, 2025 | KalVista Pharmaceuticals, Inc. (KALV) | Exercise/Conversion | 6,250 | n/a |